Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solriamfetol for Fatigue in Multiple Sclerosis
NCT06170970Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Jun 2024
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of solriamfetol in multiple sclerosis (MS), sponsored by Johns Hopkins University. Started Jun 2024; status: recruiting.
02
Drugs
solriamfetol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT06170970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06170970.